Immunologic developments in AIDS--1987.
Jacobs
J L
JL
New York Hospital, Cornell Medical Center, N.Y.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000628:therapy; D000818:Animals; D001685:Biological Factors / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D016207:Cytokines; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D005030:Ethylenes / Q000627:therapeutic use; D005814:Genes, Viral; D006678:HIV / Q000235:genetics / Q000502:physiology; D015483:HIV Antibodies / Q000276:immunology; D015488:HIV Antigens / Q000032:analysis; D000882:Haplorhini; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D051379:Mice; D015728:Receptors, HIV; D011991:Receptors, Virus; D011994:Recombinant Proteins / Q000627:therapeutic use; D012192:Retroviridae Infections / Q000276:immunology / Q000662:veterinary; D012254:Ribavirin / Q000627:therapeutic use; D015302:Simian Immunodeficiency Virus; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D014764:Viral Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology
D001685:Biological Factors; D003115:Colony-Stimulating Factors; D016207:Cytokines; D005030:Ethylenes; D015483:HIV Antibodies; D015488:HIV Antigens; D015728:Receptors, HIV; D011991:Receptors, Virus; D011994:Recombinant Proteins; D014764:Viral Proteins; D012254:Ribavirin; C054105:ammonium trichloro(dioxoethylene-O,O'-)tellurate